Index by author
November 01, 1992; Volume 20,Issue 6
Garland, W A
- You have accessDisposition of the human immunodeficiency virus Tat inhibitor, Ro 5-3335, in rats and dogs.C Town, D Chang, L Henderson and W A GarlandDrug Metabolism and Disposition November 1992, 20 (6) 954-957;
Gibson, G G
- You have accessPeroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.D E Moody, G G Gibson, D F Grant, J Magdalou and M S RaoDrug Metabolism and Disposition November 1992, 20 (6) 779-791;
Goldman, M E
- You have accessMetabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.S K Balani, S M Pitzenberger, L R Kauffman, B H Arison, H G Ramjit, M E Goldman, J A O'Brien, J D King, J M Hoffman and C S RooneyDrug Metabolism and Disposition November 1992, 20 (6) 869-876;
Granneman, G R
- You have accessSimultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.S K Gupta, G R Granneman, R S Boger, N K Hollenberg and R R LutherDrug Metabolism and Disposition November 1992, 20 (6) 821-825;
Grant, D F
- You have accessPeroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.D E Moody, G G Gibson, D F Grant, J Magdalou and M S RaoDrug Metabolism and Disposition November 1992, 20 (6) 779-791;
Green, M D
- You have accessStudies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomes.P B Styczynski, M D Green, B Coffman and T R TephlyDrug Metabolism and Disposition November 1992, 20 (6) 896-901;
Guaitani, A
- You have accessPharmacokinetic profile of theophylline in isolated perfused liver of rabbits at different ages. Development of drug-metabolizing activity during ontogenesis.M Corada, A Bortolotti, M M Barzago, A Celardo, M Bonati and A GuaitaniDrug Metabolism and Disposition November 1992, 20 (6) 826-831;
Gupta, S K
- You have accessSimultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study.S K Gupta, G R Granneman, R S Boger, N K Hollenberg and R R LutherDrug Metabolism and Disposition November 1992, 20 (6) 821-825;
In this issue
Advertisement